世界のヒトミルクオリゴ糖(HMO)市場2022年-2027年:成長・動向・新型コロナの影響・市場予測

【英語タイトル】Global Human Milk Oligosaccharides Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

Mordor Intelligenceが出版した調査資料(MOR22FB172)・商品コード:MOR22FB172
・発行会社(調査会社):Mordor Intelligence
・発行日:2022年1月
・ページ数:85
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後2-3営業日)
・調査対象地域:グローバル
・産業分野:食品
◆販売価格オプション(消費税別)
Single User(1名利用)USD4,750 ⇒換算¥703,000見積依頼/購入/質問フォーム
Team User(5名利用)USD6,500 ⇒換算¥962,000見積依頼/購入/質問フォーム
Corporate License(法人利用)USD8,750 ⇒換算¥1,295,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

Mordor Intelligence社は、世界のヒトミルクオリゴ糖(HMO)市場規模が2020年から2025年まで、年平均8.5%成長すると予測しています。本調査レポートでは、ヒトミルクオリゴ糖(HMO)の世界市場について調査し、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、用途別(乳児用調製粉乳、栄養補助食品、機能性食品・飲料)分析、地域別(北米、ヨーロッパ、アジア太平洋、その他地域)分析、競争状況、市場機会・将来傾向などを掲載しています。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・市場動向
・世界のヒトミルクオリゴ糖(HMO)市場規模:用途別(乳児用調製粉乳、栄養補助食品、機能性食品・飲料)
・世界のヒトミルクオリゴ糖(HMO)市場規模:地域別(北米、ヨーロッパ、アジア太平洋、その他地域)
・競争状況(ZuChem Inc.、Elicityl SA、Jennewein Biotechnologie GmbH、Royal FrieslandCampina NV、BASF、DuPont Nutrition & Health、Gnubiotics、Inbiose NV)
・市場機会・将来傾向

Global Human Milk Oligosaccharides Market is growing by registering a CAGR of 8.5% during the forecast period(2020-2025).

Key Highlights

  • Increased applications in infant formula, followed by dietary supplements, are expected to drive the market during the forecast period.
  • The market is also driven by the various health benefits of the HMOs. The combined prebiotic, antimicrobial, and antiadhesive effects of HMOs contribute to shaping the infant gut microbiome early in life, reducing the risk of acute diseases also that of non-communicable diseases such as asthma and allergic diseases.
  • Infant formula held a prominent share in the market studied in 2018, attributed by the increased investments in R&D activities by the global players for high product innovation on a large scale for the commercial production of HMOs.

Key Market Trends

Increasing Acceptance Of HMO

Human milk oligosaccharides are the key components of human milk and appear in various compositions and concentrations. In the regulatory sense, HMOs are novel food or ingredients that require safety assessment. In the United States, the HMO’s intended for use in food other than dietary supplements are regulated under GRAS. In U.S CARE4U™ by DuPont was approved as GRAS, for use in infant formula and toddler foods. With the increasing demand for HMOs, in 2018, two HMO’s have gone through the novel food safety assessment in Europe, with a positive assessment outcome and approval by the European Commission.

United States Held a Major Share in the Global Market

North America holds a prominent market share in the market, as many global players, are launching new product lines, with HMO as the key ingredient in the region. Increasing customer awareness in the region, about the health benefits of HMO in infant nutrition is one of the key factors aiding the market to grow further in the country with various product launches. For instance, in 2016, 2’-fucosyllactose was produced by Jennewein Biotechnologie GmbH, for the first time as a food-grade quality product to meet the demand of the US infant formula market. With the rise in inclusion of HMO in prebiotics as it helps in developing commensal bacteria and the increasing demand for functional food and beverages, and the dietary supplements for better health and digestion, the market for HMO is expected to grow in the region during the forecast period.

Competitive Landscape

Global Human Milk Oligosaccharides market is a fragmented market. BASF Corporation, DuPont Nutrition, and Health, ZuChem Inc., are among the most active companies in the HMO market. Companies are investing highly on R&D, in order to develop products with similar health benefits as that of breast milk.Key strategies adopted by players in the market are partnerships for extended research activities and new product launches.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support
❖ レポートの目次 ❖

1 INTRODUCTION
1.1 Study Deliverables & Assumptions
1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY
3.1 Market Overview

4 MARKET DYNAMICS
4.1 Market Drivers
4.2 Market Restraints
4.3 Porter’s Five Forces Analysis
4.3.1 Threat of New Entrants
4.3.2 Bargaining Power of Consumers
4.3.3 Bargaining Power of Suppliers
4.3.4 Threat of Substitute Products
4.3.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION
5.1 By Application
5.1.1 Infant Formula
5.1.2 Dietary Supplements
5.1.3 Functional Food and Beverage
5.2 Geography
5.2.1 North America
5.2.1.1 United States
5.2.1.2 Canada
5.2.1.3 Rest of North America
5.2.2 Europe
5.2.2.1 Spain
5.2.2.2 United Kingdom
5.2.2.3 Germany
5.2.2.4 France
5.2.2.5 Rest of Europe
5.2.3 Asia Pacific
5.2.3.1 China
5.2.3.2 Japan
5.2.3.3 Australia
5.2.3.4 Rest of Asia-Pacific
5.2.4 Rest of the World
5.2.4.1 South America
5.2.4.2 Middle East & Africa

6 COMPETITIVE LANDSCAPE
6.1 Most Active Companies
6.2 Most Adopted Strategies
6.3 Market Share Analysis
6.4 Company Profiles
6.4.1 ZuChem Inc.
6.4.2 Elicityl SA
6.4.3 Jennewein Biotechnologie GmbH
6.4.4 Royal FrieslandCampina NV
6.4.5 BASF
6.4.6 DuPont Nutrition & Health
6.4.7 Gnubiotics
6.4.8 Inbiose NV

7 MARKET OPPORTUNITIES AND FUTURE TRENDS



★調査レポート[世界のヒトミルクオリゴ糖(HMO)市場2022年-2027年:成長・動向・新型コロナの影響・市場予測] (コード:MOR22FB172)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のヒトミルクオリゴ糖(HMO)市場2022年-2027年:成長・動向・新型コロナの影響・市場予測]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆